We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

65 hedge funds and large institutions have $195M invested in Autolus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

454% more call options, than puts

Call options by funds: $72K | Put options by funds: $13K

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

4% less capital invested

Capital invested by funds: $204M → $195M (-$9.03M)

3.41% less ownership

Funds ownership: 64.69% → 61.28% (-3.4%)

8% less funds holding

Funds holding: 71 → 65 (-6)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
65
Holders Change
-6
Holders Change %
-8.45%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
20
Reduced
11
Closed
14
Calls
$72K
Puts
$13K
Net Calls
+$59K
Net Calls Change
-$272K

Top Buyers

Rank Fund Capital Flow
1
TAM
TFG Asset Management
Cayman Islands
+$3.32M
2
UOC
UBS O'Connor
Illinois
+$1.48M
3
BlackRock
BlackRock
New York
+$925K
4
Millennium Management
Millennium Management
New York
+$458K
5
IAM
Innovis Asset Management
Illinois
+$247K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.44M
2
CH
CVI Holdings
Delaware
-$2.35M
3
Capital World Investors
Capital World Investors
California
-$1.19M
4
AC
Armistice Capital
New York
-$1.08M
5
SFM
Sphera Funds Management
Israel
-$950K
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
$394K -$2.44M -1,250,000 -85%
EAM
27
Erste Asset Management
Austria
$343K – – –
Cetera Investment Advisers
28
Cetera Investment Advisers
Illinois
$261K +$7.82K +4,000 +3%
CSS
29
Cubist Systematic Strategies
Connecticut
$246K +$237K +121,373 +972%
IAM
30
Innovis Asset Management
Illinois
$232K +$247K +126,106 New
Renaissance Technologies
31
Renaissance Technologies
New York
$199K +$121K +62,100 +134%
LSA
32
Leonteq Securities AG
Switzerland
$184K – – –
State Street
33
State Street
Massachusetts
$182K +$93.2K +47,690 +89%
Jane Street
34
Jane Street
New York
$176K +$187K +95,876 New
Two Sigma Investments
35
Two Sigma Investments
New York
$172K +$117K +59,739 +177%
PFM
36
Privium Fund Management
Netherlands
$124K -$89.8K -45,951 -40%
UBS Group
37
UBS Group
Switzerland
$118K +$92.6K +47,368 +279%
BHCM
38
Boulder Hill Capital Management
New York
$105K +$112K +57,191 New
Morgan Stanley
39
Morgan Stanley
New York
$104K -$76K -38,865 -41%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$98.9K – – –
WE
41
Wealth Effects
Massachusetts
$82.8K +$5.38K +2,750 +7%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$71.7K +$36.6K +18,744 +93%
LPL Financial
43
LPL Financial
California
$65K +$5.91K +3,025 +9%
TRCT
44
Tower Research Capital (TRC)
New York
$55K +$20.7K +10,603 +55%
BFM
45
Boothbay Fund Management
New York
$50.1K – – –
Goldman Sachs
46
Goldman Sachs
New York
$40.1K +$42.7K +21,817 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$37K +$39K +19,956 +35,636%
Osaic Holdings
48
Osaic Holdings
Arizona
$31.1K – – –
CC
49
Cannell Capital
Wyoming
$31K – – –
Two Sigma Advisers
50
Two Sigma Advisers
New York
$25.2K +$26.8K +13,700 New
1
2
3 4

AUTL Hedge Fund Activity: Q1 2023 in Review

65 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2023, worth a combined $195M — down 4.4% from $204M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AUTL and 9 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 20 added.

The largest buyer was TFG Asset Management, adding an estimated $3.32M. The largest seller was Alyeska Investment Group, cutting an estimated $2.44M.

  • 65 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2023, down from 71 in Q4 2022.
  • Funds reported $195M of Autolus Therapeutics stock for Q1 2023, down 4.4% quarter-over-quarter.
  • 9 funds opened new Autolus Therapeutics positions in Q1 2023 and 14 closed out, a net change of -5 holders.
  • The largest Autolus Therapeutics buyer in Q1 2023 was TFG Asset Management, an estimated $3.32M added.
  • The largest Autolus Therapeutics seller in Q1 2023 was Alyeska Investment Group, an estimated $2.44M sold.

Based on aggregated 13F filings for Q1 2023.